> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Grandfathering Drugs Sans Product Identifiers
- URL: https://www.fdaweb.com/draft-guide-on-grandfathering-drugs-sans-product-identifiers/
- Published: 2017-11-27T12:00:00.000Z
- Updated: 2026-09-14T23:03:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140203

*Federal Register* notice: FDA has made available a draft guidance entitled “Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier.” The document discusses the circumstances where packages and homogenous cases of product not labeled with a product identifier shall be exempted and grandfathered from certain drug supply security requirements. It says that a package or homogenous case of product that is not labeled with a product identifier shall be grandfathered if it was packaged by a manufacturer before 11/27/2018\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-11-27/pdf/2017-25457.pdf?ref=fdaweb.com).